BIOMx is a startup based in Israel, most recent round Series-c-plus, 2 tracked investors.
BIOMx is a company headquartered in Israel. Its most recent tracked round is Series-c-plus. Brouky records 2 investors associated with the company.
BIOMx develops natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot infections and osteomyelitis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.